Credit Suisse Starts Medpace (MEDP) at Outperform
Tweet Send to a Friend
Credit Suisse initiates coverage on Medpace (NASDAQ: MEDP) with a Outperform rating and a price target of $35.00.Analyst Erin Wilson ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE